Ravindra Vijay M, Okcu M Fatih, Ruggieri Lucia, Frank Thomas S, Paulino Arnold C, McGovern Susan L, Horne Vincent E, Dauser Robert C, Whitehead William E, Aldave Guillermo
1Division of Pediatric Neurosurgery, Texas Children's Hospital, Department of Neurosurgery, Baylor College of Medicine, Houston.
6Department of Neurosurgery, Naval Medical Center San Diego; and.
J Neurosurg Pediatr. 2021 May 28;28(2):152-159. doi: 10.3171/2020.11.PEDS20803. Print 2021 Aug 1.
The authors compared survival and multiple comorbidities in children diagnosed with craniopharyngioma who underwent gross-total resection (GTR) versus subtotal resection (STR) with radiation therapy (RT), either intensity-modulated radiation therapy (IMRT) or proton beam therapy (PBT). The authors hypothesized that there are differences between multimodal treatment methods with respect to morbidity and progression-free survival (PFS).
The medical records of children diagnosed with craniopharyngioma and treated surgically between February 1997 and December 2018 at Texas Children's Hospital were reviewed. Surgical treatment was stratified as GTR or STR + RT. RT was further stratified as PBT or IMRT; PBT was stratified as STR + PBT versus cyst decompression (CD) + PBT. The authors used Kaplan-Meier analysis to compare PFS and overall survival, and chi-square analysis to compare rates for hypopituitarism, vision loss, and hypothalamic obesity (HyOb).
Sixty-three children were included in the analysis; 49% were female. The mean age was 8.16 years (95% CI 7.08-9.27). Twelve of 14 children in the IMRT cohort underwent CD. The 5-year PFS rates were as follows: 73% for GTR (n = 31), 54% for IMRT (n = 14), 100% for STR + PBT (n = 7), and 77% for CD + PBT (n = 11; p = 0.202). The overall survival rates were similar in all groups. Rates of hypopituitarism (96% GTR vs 75% IMRT vs 100% STR + PBT, 50% CD + PBT; p = 0.023) and diabetes insipidus (DI) (90% GTR vs 61% IMRT vs 85% STR + PBT, 20% CD + PBT; p = 0.004) were significantly higher in the GTR group. There was no significant difference in the HyOb or vision loss at the end of study follow-up among the different groups. Within the PBT group, 2 patients presented a progressive vasculopathy with subsequent strokes. One patient experienced a PBT-induced tumor.
GTR and CD + PBT presented similar rates of 5-year PFS. Hypopituitarism and DI rates were higher with GTR, but the rate of HyOb was similar among different treatment modalities. PBT may reduce the burden of hypopituitarism and DI, although radiation carries a risk of potential serious complications, including progressive vasculopathy and secondary malignancy. Further prospective study comparing neurocognitive outcomes is necessary.
作者比较了接受全切除(GTR)与次全切除(STR)联合放射治疗(RT)(包括调强放射治疗(IMRT)或质子束治疗(PBT))的颅咽管瘤患儿的生存率和多种合并症情况。作者假设在多模式治疗方法之间,在发病率和无进展生存期(PFS)方面存在差异。
回顾了1997年2月至2018年12月在德克萨斯儿童医院诊断为颅咽管瘤并接受手术治疗的患儿的病历。手术治疗分为GTR或STR + RT。RT进一步分为PBT或IMRT;PBT分为STR + PBT与囊肿减压(CD)+ PBT。作者使用Kaplan-Meier分析比较PFS和总生存期,并使用卡方分析比较垂体功能减退、视力丧失和下丘脑肥胖(HyOb)的发生率。
63名儿童纳入分析;49%为女性。平均年龄为8.16岁(95%CI 7.08 - 9.27)。IMRT队列中的14名儿童中有12名接受了CD。5年PFS率如下:GTR为73%(n = 31),IMRT为54%(n = 14),STR + PBT为100%(n = 7),CD + PBT为77%(n = 11;p = 0.202)。所有组的总生存率相似。垂体功能减退率(GTR为96%,IMRT为75%,STR + PBT为100%,CD + PBT为50%;p = 0.023)和尿崩症(DI)率(GTR为90%,IMRT为61%,STR + PBT为85%,CD + PBT为20%;p = 0.004)在GTR组显著更高。在研究随访结束时,不同组之间的HyOb或视力丧失无显著差异。在PBT组中,2例患者出现进行性血管病变并随后发生中风。1例患者发生PBT诱导的肿瘤。
GTR和CD + PBT的5年PFS率相似。GTR的垂体功能减退和DI率更高,但不同治疗方式之间的HyOb率相似。PBT可能减轻垂体功能减退和DI的负担,尽管放疗存在潜在严重并发症风险,包括进行性血管病变和继发性恶性肿瘤。有必要进一步进行前瞻性研究比较神经认知结局。